Reverse Payment Patent Settlements in the Pharmaceutical Sector and Competition Law – Do Lundbeck and Actavis Help to Bridge the Views Across the Atlantic Regarding the Delayed Market Entry of Cheaper, Generic Medicines? Cover

.blurhash-client-img { display: none !important; }

Reverse Payment Patent Settlements in the Pharmaceutical Sector and Competition Law – Do Lundbeck and Actavis Help to Bridge the Views Across the Atlantic Regarding the Delayed Market Entry of Cheaper, Generic Medicines?

International and Comparative Law Review

Volume 13 (2013): Issue 1 (June 2013)

By: Pawan Dutt and Tanel Kerikmäe

Open Access

|Jan 2018

DOI: https://doi.org/10.1515/iclr-2016-0056 | Journal eISSN: 2464-6601 | Journal ISSN: 12138770

Journal RSS Feed

Language: English

Page range: 23 - 38

Published on: Jan 24, 2018

Published by: Palacký University Olomouc

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

intellectual property,

pharmaceutical industry,

reverse payment patent,

European Union,

Related subjects:

International law, foreign law, comparative law,

International law, foreign law, comparative law, other,

European law, other,

Constitutional jurisdiction, administrative procedural law

© 2018 Pawan Dutt, Tanel Kerikmäe, published by Palacký University Olomouc
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 13 (2013): Issue 1 (June 2013)Next article